Skip to content
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients […]
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
International partnerships are vital to delivering new biotech solutions for the health of people and the planet—and strong policies, both in the U.S. and
BIO Asia-Taiwan 2023 highlights importance of cross-border collaboration Read More »
Federal support empowers a public-private partnership that helps ensure U.S. leadership in drug development—and the relationship should not be changed by calls for arbitrary
BIO expert lauds beautiful relationship between NIH and biotech Read More »
International research collaboration just got easier thanks to a new agreement that allows for more secure and robust sharing of data between Europe and
Biotech benefits as EU and U.S. agree to enhanced data sharing framework Read More »
COVID-19 has affected the world for nearly four years, persisting in its consequences through post-viral syndrome. Scientists are gaining deeper insights into the causes
Unraveling causes of long COVID to find potential treatments Read More »
A boy with a rare genetic condition has regained his sight thanks to creative “off-label” use of a gene therapy—an innovative approach that current
Off-label use of a gene therapy returns sight for boy with rare disease Read More »
On July 20, seven pharmaceutical companies announced the formation of a new international alliance to help prepare the world for the next pandemic –
INTREPID Alliance seeks 25 new pandemic-ready antivirals Read More »
Already a leader in biotech for agriculture, Bayer announced plans to double its Crop Sciences Division with a major push into regenerative farming. Along
Bayer digs into regenerative farming through biotech Read More »
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House
PAHPA legislation moves forward in Senate and House Read More »
On July 17, Eli Lilly announced positive results from clinical trials of donanemab, the company’s candidate for the treatment of Alzheimer’s disease. The drug
Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline Read More »
